News and Announcements
EDITORIAL
A paradigm shift in gastric cancer management: From reactive treatment to proactive prevention—insights from Weifuchun, a Chinese patent medicine
Show Less
1 College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang,
China
2 State Key Laboratory of Chinese Medicine Modernization, Zhejiang University, Hangzhou, Zhejiang,
China
EJMO, 026050056 https://doi.org/10.36922/EJMO026050056
Received: 31 January 2026 | Accepted: 7 April 2026 | Published online: 7 May 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC-by the license) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Conflict of interest
Zhenyu Luo serves as an Editorial Board Member of this journal but was not in any way involved in the editorial and peer review process conducted for this paper, directly or indirectly.
References
- Wang L, Ding X, Li P, et al. Efficacy and safety of Weifuchun tablet for chronic atrophic gastritis: A systematic review and meta-analysis. PLoS One. 2023;18(4):e0284411. doi: 10.1371/journal.pone.0284411
- Wu Y, Hu L. Therapeutic effect and safety of Wei-Fu-Chun in the treatment of chronic atrophic gastritis: a network meta-analysis. Front Pharmacol. 2025;16:1693427. doi: 10.3389/fphar.2025.1693427
- Xie D, Wu C, Wang D, et al. Wei-fu-chun tablet halted gastric intestinal metaplasia and dysplasia associated with inflammation by regulating the NF-κB pathway. J Ethnopharmacol. 2024;318(Pt B):117020.doi: 10.1016/j.jep.2023.117020
- Wang H, Wu R, Xie D, et al. A Combined Phytochemistry and Network Pharmacology Approach to Reveal the Effective Substances and Mechanisms of Wei-Fu-Chun Tablet in the Treatment of Precancerous Lesions of Gastric Cancer. Front Pharmacol. 2020;11:558471. doi: 10.3389/fphar.2020.558471
- Zhong Y, Wen W, Luo Z, Cheng N. A multi-component, multi-target, and multi-pathway prediction method for Chinese medicine based on the combination of mass spectrometry analysis and network analysis: An example using Weifuchun. J Chromatogr A. 2024;1731:465164. doi: 10.1016/j.chroma.2024.465164
- Ma L, Hu X, Zhang W, Qi D, Chen L, Yin M. Weifuchun suppresses the malignancy of gastric cancer cells by targeting KPNA2 through miR-26a-5p-mediated destabilization and the deactivation of the MAPK signaling pathway. J Ethnopharmacol. 2024;334:118538. doi: 10.1016/j.jep.2024.118538
- Xie W, Wang N, Wang M, et al. Gut microbiome modulation by Weifuchun Capsules alleviates chronic atrophic gastritis: a combined microbiota and metabolomics approach. Front Microbiol. 2025;16:1634410. doi: 10.3389/fmicb.2025.1634410
- Chen Y, Feng P, Lou X, et al. Weifuchun alleviates MNNG-induced chronic atrophic gastritis by improving the gastric and intestinal microbiota homeostasis. PLoS One. 2025;20(11):e0333375. doi: 10.1371/journal.pone.0333375
- Wang B, Zhou W, Zhang H, Wang W, Zhang B, Li S. Exploring the effect of Weifuchun capsule on the toll-like receptor pathway mediated HES6 and immune regulation against chronic atrophic gastritis. J Ethnopharmacol. 2023;303:115930. doi: 10.1016/j.jep.2022.115930
- Shao W, Zhao X, Zhou Q, Ma L, Zhang W, Tao Y. Pharmacokinetic investigation on eight primary active constituents of Weifuchun capsules in healthy and chronic atrophic gastritis model rats. J Pharm Biomed Anal. 2026;271:117335. doi: 10.1016/j.jpba.2026.117335
- Luo Z, Xu Y, Wang Y, Cheng N. Identifying active compounds and revealing integrated mechanism of phytomedicines via AI-driven chemical-biological information fusion: a case study of Weifuchun. J Ethnopharmacol. 2026;366:121598. doi: 10.1016/j.jep.2026.121598